Keeping public institutions invested in tobacco
Journal of Business Ethics 73 (2):161 - 176 (2007)
| Abstract | Increasingly through the 1990s, tobacco control advocates questioned the practice of public institutions investing in tobacco company stocks. The questioning was framed in at least three ways. First, is it ethical to fund public expenditures with profits from a product that causes addiction and disease? Second, is it sound social policy to derive public income from a product that increases healthcare costs and reduces worker productivity? Finally, is it sound fiscal policy to invest in an historically profitable industry facing multiplying legal and regulatory challenges? While the tobacco industry preferred to restrict discussion to the fiscal question, and offered an affirmative answer, its position was weakened by depressed stock prices brought on by actions of the industry as much as by tobacco control activism. As part of a campaign to restore its credibility as an investment vehicle with public fund managers, Philip Morris (PM) commissioned a report from the influential investment managers/advisors Wilshire Associates. However, Wilshire had only recently conducted such a study for the Washington State Investment Board (WSIB), assuring the board that the value tobacco stocks added to an investment portfolio – if any – was too small to be measured. Nonetheless, within a year, Wilshire produced a report for PM which appeared to laud the investment value of tobacco and to dismiss tobacco-excluded investment alternatives. This paper examines how Wilshire produced apparently diametrically opposed reports for clients with different interests. It reveals a pattern of potential conflicts of interest among tobacco companies, financial analysis firms, investment authorities, and institutional fund managers. It demonstrates substantial violations of two generally accepted ethical principles of business consulting: veracity and transparency. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,664 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesE. Breton & W. Sherlaw (2011). Examining Tobacco Control Strategies and Aims Through a Social Justice Lens: An Application of Sen's Capability Approach. Public Health Ethics 4 (2):149-159.
David A. Bella (1997). Organized Complexity in Human Affairs: The Tobacco Industry. Journal of Business Ethics 16 (10):977-999.
Michelle Inness, Julian Barling, Keith Rogers & Nick Turner (2008). De-Marketing Tobacco Through Price Changes and Consumer Attempts Quit Smoking. Journal of Business Ethics 77 (4):405 - 416.
Patrizia Russo, Candida Nastrucci, Giulio Alzetta & Clara Szalai (2011). Tobacco Habit: Historical, Cultural, Neurobiological, and Genetic Features of People's Relationship with an Addictive Drug. Perspectives in Biology and Medicine 54 (4):557-577.
A. Bitton & N. Eyal (2011). Too Poor To Treat? The Complex Ethics of Cost-Effective Tobacco Policy in the Developing World. Public Health Ethics 4 (2):109-120.
Steven R. Thomsen (1998). Public Relations and the Tobacco Industry: Examining the Debate on Practictioner Ethics. Journal of Mass Media Ethics 13 (3):152 – 164.
Mark S. Schwartz (2003). The "Ethics" of Ethical Investing. Journal of Business Ethics 43 (3):195 - 213.
Guido Palazzo & Ulf Richter (2005). CSR Business as Usual? The Case of the Tobacco Industry. Journal of Business Ethics 61 (4):387 - 401.
William R. Pasewark & Mark E. Riley (2010). It's a Matter of Principle: The Role of Personal Values in Investment Decisions. Journal of Business Ethics 93 (2).
Derek Yach (2001). Healthy Investments in Investing in Health. Journal of Business Ethics 33 (3):191 - 198.
Analytics
Monthly downloads |
Added to index2009-01-28Total downloads2 ( #232,316 of 549,014 )Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
